FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3098045374> ?p ?o ?g. }

• W3098045374 endingPage "2532" @default.
• W3098045374 startingPage "2519" @default.
• W3098045374 abstract "5-Alpha-reductase inhibitors (5-ARIs) have been suggested as potential chemopreventive agents for prostate cancer (PCa). This study was conducted to evaluate the effect of 5-ARIs on the incidence and mortality of PCa.The PubMed, Embase and Cochrane Library databases were searched comprehensively from database inception to October 2019. The clinical outcomes included the incidence of overall PCa, high-grade (Gleason8-10) PCa, metastatic PCa, overall survival (OS), and cancer-specific survival (CSS).Overall, 23 studies were included in the present study, representing 11 cohort studies, 5 case-control studies, and 8 randomized controlled trials. The use of 5-ARIs was associated with a decreased risk of overall PCa [relative risk (RR) =0.77; 95% CI: 0.67-0.88; P<0.001] and increased risk of Gleason 8-10 PCa (RR=1.19; 95% CI: 1.01-1.40; P=0.036). In terms of metastatic PCa, there were no significant between-group differences (RR=1.23; 95% CI: 0.69-2.18; P=0.487). Furthermore, we found that prediagnostic 5-ARI usage was not associated with an increased risk of overall or prostate cancer mortality, with HRs of 1.00 (95% CI: 0.92-1.08; P=0.938) and 0.98 (95% CI: 0.80-1.21; P=0.881), respectively.In conclusion, while male 5-ARI users were associated with a decreased risk of overall prostate cancer and increased risk of high-grade prostate cancer (Gleason 8-10), they were not associated with an increased risk of overall or prostate cancer mortality. 5-ARIs should be recommended carefully for use as chemopreventive agents." @default.
• W3098045374 created "2020-11-23" @default.
• W3098045374 creator A5032862669 @default.
• W3098045374 creator A5035480324 @default.
• W3098045374 creator A5051074094 @default.
• W3098045374 creator A5078517869 @default.
• W3098045374 creator A5083752851 @default.
• W3098045374 creator A5087788392 @default.
• W3098045374 date "2020-12-01" @default.
• W3098045374 modified "2023-10-13" @default.
• W3098045374 title "Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis" @default.
• W3098045374 cites W1970995194 @default.
• W3098045374 cites W1980738720 @default.
• W3098045374 cites W1984290267 @default.
• W3098045374 cites W1998455906 @default.
• W3098045374 cites W2002664683 @default.
• W3098045374 cites W2012608816 @default.
• W3098045374 cites W2020095621 @default.
• W3098045374 cites W2023481449 @default.
• W3098045374 cites W2032356714 @default.
• W3098045374 cites W2033585778 @default.
• W3098045374 cites W2034621471 @default.
• W3098045374 cites W2056530886 @default.
• W3098045374 cites W2071679886 @default.
• W3098045374 cites W2089030366 @default.
• W3098045374 cites W2093593899 @default.
• W3098045374 cites W2098923148 @default.
• W3098045374 cites W2110708036 @default.
• W3098045374 cites W2121759271 @default.
• W3098045374 cites W2123411838 @default.
• W3098045374 cites W2125435699 @default.
• W3098045374 cites W2127923363 @default.
• W3098045374 cites W2129302529 @default.
• W3098045374 cites W2131125612 @default.
• W3098045374 cites W2133455047 @default.
• W3098045374 cites W2152765363 @default.
• W3098045374 cites W2155530804 @default.
• W3098045374 cites W2156098321 @default.
• W3098045374 cites W2160699421 @default.
• W3098045374 cites W2170621307 @default.
• W3098045374 cites W246286872 @default.
• W3098045374 cites W2476646956 @default.
• W3098045374 cites W2519083458 @default.
• W3098045374 cites W2540045475 @default.
• W3098045374 cites W2588071971 @default.
• W3098045374 cites W2588681363 @default.
• W3098045374 cites W2791714174 @default.
• W3098045374 cites W2883706387 @default.
• W3098045374 cites W2889646458 @default.
• W3098045374 cites W2890743632 @default.
• W3098045374 cites W2944049715 @default.
• W3098045374 cites W3135529189 @default.
• W3098045374 doi "https://doi.org/10.21037/tau-20-843" @default.
• W3098045374 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7807305" @default.
• W3098045374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33457226" @default.
• W3098045374 hasPublicationYear "2020" @default.
• W3098045374 type Work @default.
• W3098045374 sameAs 3098045374 @default.
• W3098045374 citedByCount "5" @default.
• W3098045374 countsByYear W30980453742022 @default.
• W3098045374 countsByYear W30980453742023 @default.
• W3098045374 crossrefType "journal-article" @default.
• W3098045374 hasAuthorship W3098045374A5032862669 @default.
• W3098045374 hasAuthorship W3098045374A5035480324 @default.
• W3098045374 hasAuthorship W3098045374A5051074094 @default.
• W3098045374 hasAuthorship W3098045374A5078517869 @default.
• W3098045374 hasAuthorship W3098045374A5083752851 @default.
• W3098045374 hasAuthorship W3098045374A5087788392 @default.
• W3098045374 hasBestOaLocation W30980453741 @default.
• W3098045374 hasConcept C120665830 @default.
• W3098045374 hasConcept C121332964 @default.
• W3098045374 hasConcept C121608353 @default.
• W3098045374 hasConcept C126322002 @default.
• W3098045374 hasConcept C143998085 @default.
• W3098045374 hasConcept C201903717 @default.
• W3098045374 hasConcept C2776235491 @default.
• W3098045374 hasConcept C2776478404 @default.
• W3098045374 hasConcept C2780192828 @default.
• W3098045374 hasConcept C44249647 @default.
• W3098045374 hasConcept C61511704 @default.
• W3098045374 hasConcept C71924100 @default.
• W3098045374 hasConcept C72563966 @default.
• W3098045374 hasConcept C82789193 @default.
• W3098045374 hasConcept C95190672 @default.
• W3098045374 hasConceptScore W3098045374C120665830 @default.
• W3098045374 hasConceptScore W3098045374C121332964 @default.
• W3098045374 hasConceptScore W3098045374C121608353 @default.
• W3098045374 hasConceptScore W3098045374C126322002 @default.
• W3098045374 hasConceptScore W3098045374C143998085 @default.
• W3098045374 hasConceptScore W3098045374C201903717 @default.
• W3098045374 hasConceptScore W3098045374C2776235491 @default.
• W3098045374 hasConceptScore W3098045374C2776478404 @default.
• W3098045374 hasConceptScore W3098045374C2780192828 @default.
• W3098045374 hasConceptScore W3098045374C44249647 @default.
• W3098045374 hasConceptScore W3098045374C61511704 @default.
• W3098045374 hasConceptScore W3098045374C71924100 @default.
• W3098045374 hasConceptScore W3098045374C72563966 @default.
• W3098045374 hasConceptScore W3098045374C82789193 @default.

• next